Literature DB >> 15126900

Genetics of primary aldosteronism.

Paolo Mulatero1, Fulvio Morello, Franco Veglio.   

Abstract

Over the last few years, much progress has been made in understanding the genetic basis of primary aldosteronism. This has led to the diagnosis of the familial forms and has aided the understanding of the basis of sporadic forms of the disease. Such information can be exploited to improve the therapeutic approaches used not only for patients with primary aldosteronism, but also with other forms of hypertension. Here, we review the genetic and the phenotypic features of the familial forms, the genetic variants that influence the sporadic forms and the structure and regulation of the CYP11B1 and CYP11B2 genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126900     DOI: 10.1097/00004872-200404000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

Review 1.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 2.  Differential diagnosis of primary aldosteronism subtypes.

Authors:  Paolo Mulatero; Chiara Bertello; Andrea Verhovez; Denis Rossato; Giuseppe Giraudo; Giulio Mengozzi; Giorgio Limerutti; Eleonora Avenatti; Davide Tizzani; Franco Veglio
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 3.  Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.

Authors:  Silvia Monticone; Tobias Else; Paolo Mulatero; Tracy A Williams; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2014-09-18       Impact factor: 4.102

Review 4.  Genetic information in the diagnosis and treatment of hypertension.

Authors:  Maciej Tomaszewski; Lukas Zimmerli; Fadi J Charchar; Anna F Dominiczak
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 5.  Who should be screened for primary aldosteronism? A comprehensive review of current evidence.

Authors:  Wei-Chieh Huang; Yen-Hung Lin; Vin-Cent Wu; Chen-Huan Chen; Saulat Siddique; Yook-Chin Chia; Jam Chin Tay; Guruprasad Sogunuru; Hao-Min Cheng; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.